rs41309435
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001626.6(AKT2):c.1110G>T(p.Pro370=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00284 in 1,613,886 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0030 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 17 hom. )
Consequence
AKT2
NM_001626.6 synonymous
NM_001626.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.88
Genes affected
AKT2 (HGNC:392): (AKT serine/threonine kinase 2) This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 19-40235955-C-A is Benign according to our data. Variant chr19-40235955-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 466265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-40235955-C-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.88 with no splicing effect.
BS2
High AC in GnomAd4 at 457 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKT2 | NM_001626.6 | c.1110G>T | p.Pro370= | synonymous_variant | 11/14 | ENST00000392038.7 | NP_001617.1 | |
AKT2 | NM_001330511.1 | c.981G>T | p.Pro327= | synonymous_variant | 9/12 | NP_001317440.1 | ||
AKT2 | NM_001243027.3 | c.924G>T | p.Pro308= | synonymous_variant | 11/14 | NP_001229956.1 | ||
AKT2 | NM_001243028.3 | c.924G>T | p.Pro308= | synonymous_variant | 10/13 | NP_001229957.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKT2 | ENST00000392038.7 | c.1110G>T | p.Pro370= | synonymous_variant | 11/14 | 1 | NM_001626.6 | ENSP00000375892 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00300 AC: 457AN: 152110Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
457
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00342 AC: 858AN: 250904Hom.: 10 AF XY: 0.00323 AC XY: 439AN XY: 135774
GnomAD3 exomes
AF:
AC:
858
AN:
250904
Hom.:
AF XY:
AC XY:
439
AN XY:
135774
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00282 AC: 4120AN: 1461658Hom.: 17 Cov.: 33 AF XY: 0.00273 AC XY: 1985AN XY: 727134
GnomAD4 exome
AF:
AC:
4120
AN:
1461658
Hom.:
Cov.:
33
AF XY:
AC XY:
1985
AN XY:
727134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00300 AC: 457AN: 152228Hom.: 3 Cov.: 32 AF XY: 0.00387 AC XY: 288AN XY: 74418
GnomAD4 genome
AF:
AC:
457
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
288
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | AKT2: BP4, BP7 - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Type 2 diabetes mellitus;C3278384:Hypoinsulinemic hypoglycemia and body hemihypertrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 10, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at